Paclitaxel Injection 30mg
Paclitaxel Injection 30mg
Paclitaxel, a new anticancer agent first isolated from the bark of Taxus brevifolia, has a wide spectrum of antineoplastic activity. It has in vitro cytotoxicity against human ovary, breast, cervical, pancreas, prostate, head and neck, colon, gastric, bladder, lung and CNS cancers, melanoma, hepatoma and leukaemia cell lines, often at concentrations lower than those achieved in the serum of patients. Similarly, fresh human lung, ovarian, breast and endometrial cancer cells, sarcoma and leukaemia cells are sensitive to paclitaxel. Paclitaxel Injection 30mg/5ml filled in a clear mpoulded glass vial USP Type 1.
Send Enquiry
